Putting Patients First
We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”
We are advancing an innovative, high-value product portfolio for patients globally.
Passion with Purpose
We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.
January 19, 2023
BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRARead more
January 18, 2023
BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug ListRead more
January 17, 2023